Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,254.00
Bid: 12,252.00
Ask: 12,256.00
Change: 84.00 (0.69%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,254.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks down as BoE confirms end to bond-buying

Wed, 12th Oct 2022 17:00

(Alliance News) - Stock prices in London closed in the red on Wednesday, as discouraging economic data and mixed signals from the UK's central bank weighed on investor sentiment.

The FTSE 100 index closed down 59.08 points, 0.9%, at 6,826.15. The FTSE 250 ended down 292.90 points, 1.7%, at 16,611.16, and the AIM All-Share closed down 11.43 points, 1.5%, at 776.27.

The Cboe UK 100 ended down 0.9% at 681.94, the Cboe UK 250 closed down 2.0% at 14,231.10, and the Cboe Small Companies ended down 1.7% at 12,308.79.

In European equities on Wednesday, the CAC 40 in Paris ended down 0.3%, while the DAX 40 in Frankfurt ended down 0.4%.

The UK economy faced yet more turmoil, with economic data painting a fairly gloomy picture.

The nation's trade deficit widened, its industrial production shrunk and its gross domestic product also weakened.

Figures showed the UK economy shrank by 0.3% in August from July, following a downwardly revised 0.1% climb in July from June. Month-on-month growth in July was initially forecast at 0.2%.

August's gross domestic product was expected to have remained unchanged from July.

"While July's economic health was bolstered by a number of sporting events that got people out and about, August was coloured with caution. Households were terrified about what the winter ahead had in store, as they read headlines predicting horrific energy bills, and witnessed first-hand as inflation squeezed their spending power," said AJ Bell's Danni Hewson.

"Rising prices, falling confidence and cooling temperatures seem to be the perfect recipe for recession and there's every indication that in September the economy will have followed August's path, helped along by a bank holiday detour."

The pound was quoted at USD1.1066 at the London equities close Wednesday, down compared to USD1.1097 at the close on Tuesday. It had hit a two-week low of USD1.0924 earlier in the day.

Sterling saw a turbulent day of trading, following some mixed messages from the Bank of England.

BoE Governor Andrew Bailey confirmed late Tuesday that the emergency interventions would halt this week, but on Wednesday morning, the Financial Times reported the bank had privately signalled it was considering extending the bond-buying programme beyond the Friday deadline.

Later in the day, the bank confirmed the scheme would end on Friday.

"The Bank of England's messaging to the market over the last 24-hours has been conflicted and confused, causing unnecessary gyrations to the pound and adding to the sense of instability in the markets," interactive investor's Victoria Scholar commented.

The euro stood at USD0.9702 at the European equities close Wednesday, down against USD0.9719 at the same time on Tuesday.

Against the yen, the dollar was trading at JPY146.90, sharply higher compared to JPY145.70 late Tuesday.

Meanwhile, producer inflation heated up in the US. Producer prices increased in September, data from the Bureau of Labor Statistics showed, reversing from August's decline and exceeding market expectations.

The producer price index increased 0.4% in September from the previous month, partially reversing declines of 0.2% in August and 0.4% in July.

Market consensus, according to FX Street, had predicted a 0.2% rise.

Investors will have a keen eye on Thursday's US consumer price inflation figures, which will be a key factor in determining the US Federal Reserve's interest rate decision next month.

Stocks in New York were higher at the London equities close, with the DJIA up 0.5%, the S&P 500 index 0.2%, and the Nasdaq Composite up 0.2%.

In the FTSE 100, AstraZeneca edged up 1.1% on "exceptional data" for its drug Ultomiris. Towards the end of this month, AZ's subsidiary Alexion Pharmaceuticals will present data showing "significant advances" for the treatment of a form of neuromyelitis.

At the other end of the index was JD Sports, which lost 9.7%. After some high-profile changes to its once controversial leadership in recent months, the athleisure retailer announced its Chief Financial Officer Neil Greenlagh will step down next year.

JD will now begin the process of recruiting his successor.

Another poor blue chip performer was Barratt Homes, falling 5.0%. The housebuilder warned private reservations are down from a year earlier, as the sector battles a tough economic climate.

"Barratt cites increased wider economic uncertainty thanks to the knock to consumers' confidence and pockets from the increased cost of living, higher interest rates and also a reduction in mortgage availability. All three factors bear the fingerprints of both the government and the Bank of England and the drop in mortgage availability is a direct result of the financial market fall-out which followed the chancellor's botched fiscal event of 23 September," said AJ Bell investment director, Russ Mould.

In a negative read-across fellow housebuilders Persimmon and Crest Nicholson lost 5.8% and 6.6% respectively

In the midcaps, Marks & Spencer lost 4.8%. In a presentation to investors, the grocer said it is accelerating a major shake-up of its stores estate, and will close 67 more shops.

M&S stressed that the previously announced closures will be more than offset by new openings as the group seeks to focus more on its grocery business and online operations.

On AIM, environmental and life science group Deepverge plunged 45%.

The Dublin-based artificial intelligence tech firm warned it may not be able to raise "sufficient equity funds" as repayments for a loan fall due.

It secured a GBP25 million loan in March, of which an initial GBP4 million was drawn. The firm stated that monthly repayments begin on Sunday, with an initial GBP500,000 due.

DeepVerge added there will be no default on the loan despite any missed payments up to November 14, assuming principal and interest payments are made following a proposed equity raise.

Brent oil was quoted at USD92.55 a barrel at the London equities close Wednesday down from USD94.62 late Tuesday. Gold was quoted at USD1,670.16 an ounce, down slightly against USD1,671.20 at the close on Tuesday.

In Thursday's UK corporate calendar, there are trading statements from budget airline easyJet, gambling firm Entain, and recruitment firm Hays.

As well as US CPI and intial jobless claims at 1330 BST, the economic calendar for Thursday has German CPI at 0700 BST, and Ireland CPI at 1100 BST. There will also be remarks from BoE Monetary Policy Committee Member Catherine Mann.

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.